Baxter Cost of Goods Sold 2010-2024 | BAX
Baxter annual/quarterly cost of goods sold history and growth rate from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
- Baxter cost of goods sold for the quarter ending September 30, 2024 was $1.666B, a 7.97% increase year-over-year.
- Baxter cost of goods sold for the twelve months ending September 30, 2024 was $9.713B, a 12.02% increase year-over-year.
- Baxter annual cost of goods sold for 2023 was $9.838B, a 4.22% increase from 2022.
- Baxter annual cost of goods sold for 2022 was $9.44B, a 27.12% increase from 2021.
- Baxter annual cost of goods sold for 2021 was $7.426B, a 4.8% increase from 2020.
| Baxter Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2023 | $9,838 |
| 2022 | $9,440 |
| 2021 | $7,426 |
| 2020 | $7,086 |
| 2019 | $6,601 |
| 2018 | $6,340 |
| 2017 | $6,110 |
| 2016 | $6,047 |
| 2015 | $5,822 |
| 2014 | $6,138 |
| 2013 | $5,251 |
| 2012 | $6,802 |
| 2011 | $6,847 |
| 2010 | $6,885 |
| 2009 | $6,037 |
| Baxter Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024-09-30 | $1,666 |
| 2024-06-30 | $2,381 |
| 2024-03-31 | $2,205 |
| 2023-12-31 | $3,461 |
| 2023-09-30 | $1,543 |
| 2023-06-30 | $2,596 |
| 2023-03-31 | $2,238 |
| 2022-12-31 | $2,294 |
| 2022-09-30 | $2,564 |
| 2022-06-30 | $2,223 |
| 2022-03-31 | $2,359 |
| 2021-12-31 | $1,855 |
| 2021-09-30 | $1,905 |
| 2021-06-30 | $1,865 |
| 2021-03-31 | $1,801 |
| 2020-12-31 | $1,990 |
| 2020-09-30 | $1,777 |
| 2020-06-30 | $1,680 |
| 2020-03-31 | $1,639 |
| 2019-12-31 | $1,741 |
| 2019-09-30 | $1,621 |
| 2019-06-30 | $1,681 |
| 2019-03-31 | $1,558 |
| 2018-12-31 | $1,645 |
| 2018-09-30 | $1,529 |
| 2018-06-30 | $1,603 |
| 2018-03-31 | $1,563 |
| 2017-12-31 | $1,629 |
| 2017-09-30 | $1,577 |
| 2017-06-30 | $1,473 |
| 2017-03-31 | $1,431 |
| 2016-12-31 | $1,537 |
| 2016-09-30 | $1,487 |
| 2016-06-30 | $1,613 |
| 2016-03-31 | $1,410 |
| 2015-12-31 | $1,531 |
| 2015-09-30 | $1,453 |
| 2015-06-30 | $1,454 |
| 2015-03-31 | $1,384 |
| 2014-12-31 | $1,582 |
| 2014-09-30 | $1,516 |
| 2014-06-30 | $2,185 |
| 2014-03-31 | $1,957 |
| 2013-12-31 | $2,326 |
| 2013-09-30 | $1,804 |
| 2013-06-30 | $1,730 |
| 2013-03-31 | $1,692 |
| 2012-12-31 | $1,761 |
| 2012-09-30 | $1,667 |
| 2012-06-30 | $1,700 |
| 2012-03-31 | $1,674 |
| 2011-12-31 | $1,829 |
| 2011-09-30 | $1,708 |
| 2011-06-30 | $1,701 |
| 2011-03-31 | $1,609 |
| 2010-12-31 | $1,880 |
| 2010-09-30 | $1,565 |
| 2010-06-30 | $1,556 |
| 2010-03-31 | $1,884 |
| 2009-12-31 | $1,703 |
| 2009-09-30 | $1,513 |
| 2009-06-30 | $1,485 |
| 2009-03-31 | $1,336 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $14.940B | $14.813B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $196.757B | 25.10 |
| Stryker (SYK) | United States | $136.750B | 30.82 |
| Boston Scientific (BSX) | United States | $131.731B | 37.87 |
| EssilorLuxottica (ESLOY) | France | $109.710B | 0.00 |
| Medtronic (MDT) | Ireland | $102.865B | 15.28 |
| Haleon (HLN) | United Kingdom | $42.732B | 27.76 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.382B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $35.810B | 18.57 |
| ResMed (RMD) | United States | $33.540B | 27.56 |
| Terumo (TRUMY) | Japan | $28.681B | 40.51 |
| Koninklijke Philips (PHG) | Netherlands | $23.480B | 17.97 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.795B | 13.24 |
| Insulet (PODD) | United States | $18.017B | 71.75 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.667B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.606B | 38.65 |
| Bio-Rad Laboratories (BIO) | United States | $9.131B | 31.03 |
| Demant (WILYY) | Denmark | $8.251B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.174B | 14.35 |
| Haemonetics (HAE) | United States | $3.938B | 19.22 |
| ICU Medical (ICUI) | United States | $3.868B | 36.83 |
| Prestige Consumer Healthcare (PBH) | United States | $3.840B | 19.10 |
| Perrigo (PRGO) | Ireland | $3.547B | 10.44 |
| Envista Holdings (NVST) | United States | $3.289B | 24.50 |
| QuidelOrtho (QDEL) | United States | $3.029B | 19.50 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.863B | 18.36 |
| Neogen (NEOG) | United States | $2.587B | 29.85 |
| LeMaitre Vascular (LMAT) | United States | $2.057B | 49.98 |
| Green Thumb Industries (GTBIF) | United States | $1.724B | 30.17 |
| AtriCure (ATRC) | United States | $1.482B | 0.00 |
| InMode (INMD) | Israel | $1.424B | 8.57 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.386B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.305B | 9.33 |
| BioLife Solutions (BLFS) | United States | $1.214B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.066B | 0.00 |
| Owens & Minor (OMI) | United States | $0.991B | 7.74 |
| CeriBell (CBLL) | United States | $0.926B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.840B | 14.81 |
| Evolus (EOLS) | United States | $0.704B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.680B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.594B | 26.20 |
| Omeros (OMER) | United States | $0.570B | 0.00 |
| Surmodics (SRDX) | United States | $0.567B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.502B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.463B | 0.00 |
| Quanterix (QTRX) | United States | $0.415B | 0.00 |
| Valneva SE (VALN) | France | $0.384B | 0.00 |
| ZimVie (ZIMV) | United States | $0.382B | 32.16 |
| Biote (BTMD) | United States | $0.328B | 7.18 |
| Viemed Healthcare (VMD) | United States | $0.317B | 30.11 |
| Canopy Growth (CGC) | Canada | $0.314B | 0.00 |
| Cerus (CERS) | United States | $0.292B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.289B | 0.00 |
| High Tide (HITI) | Canada | $0.269B | 110.67 |
| OraSure Technologies (OSUR) | United States | $0.264B | 17.70 |
| Zynex (ZYXI) | United States | $0.249B | 52.07 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.208B | 14.37 |
| MacroGenics (MGNX) | United States | $0.207B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.188B | 2.64 |
| Brainsway (BWAY) | Israel | $0.180B | 95.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.152B | 0.00 |
| Jin Medical (ZJYL) | China | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.148B | 18.59 |
| Quipt Home Medical (QIPT) | United States | $0.125B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 10.79 |
| Veru (VERU) | United States | $0.095B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.072B | 37.00 |
| Jushi Holdings (JUSHF) | United States | $0.065B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.060B | 0.00 |
| Apyx Medical (APYX) | United States | $0.059B | 0.00 |
| Exagen (XGN) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.050B | 0.00 |
| Modular Medical (MODD) | United States | $0.049B | 0.00 |
| ImmuCell (ICCC) | United States | $0.047B | 0.00 |
| Safety Shot (SHOT) | United States | $0.045B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.027B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Nephros (NEPH) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.84 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |